Apyx Medical
APYX
50 hedge funds and large institutions have $41.7M invested in Apyx Medical in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 12 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
7% less funds holding
Funds holding: 54 → 50 (-4)
9.03% less ownership
Funds ownership: 60.54% → 51.5% (-9%)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
56% less capital invested
Capital invested by funds: $94M → $41.7M (-$52.3M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$2.57M |
| 2 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$2.31M |
| 3 |
CPA
Cowen Prime Advisors
New York
|
+$1.03M |
| 4 |
JP Morgan Chase
New York
|
+$725K |
| 5 |
Morgan Stanley
New York
|
+$720K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$4.71M |
| 2 |
CAC
Cowen and Company
New York
|
-$3.29M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$2.75M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.71M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$1.53M |
APYX Hedge Fund Activity: Q4 2022 in Review
50 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q4 2022, worth a combined $41.7M — down 56% from $94M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of APYX and 10 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 16 added.
The largest buyer was Barclays, opening a new position worth an estimated $2.57M. The largest seller was Kent Lake Capital, exiting entirely with an estimated $4.71M sold.
- 50 institutional investors held Apyx Medical (APYX) as of Q4 2022, down from 54 in Q3 2022.
- Funds reported $41.7M of Apyx Medical stock for Q4 2022, down 56% quarter-over-quarter.
- 10 funds opened new Apyx Medical positions in Q4 2022 and 12 closed out, a net change of -2 holders.
- The largest Apyx Medical buyer in Q4 2022 was Barclays, an estimated $2.57M added.
- The largest Apyx Medical seller in Q4 2022 was Kent Lake Capital, an estimated $4.71M sold.
Based on aggregated 13F filings for Q4 2022.